Published in Transfusion on September 20, 2013
RHD gene deletion occurred in the Rhesus box. Blood (2000) 2.75
Nomenclature of human platelet antigens. Vox Sang (2003) 1.62
Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus Med Rev (2008) 1.61
IPD--the Immuno Polymorphism Database. Nucleic Acids Res (2005) 1.60
A flexible array format for large-scale, rapid blood group DNA typing. Transfusion (2005) 1.53
Characterization of the human neutrophil alloantigen-3a. Nat Med (2009) 1.43
Report of the third international workshop on molecular blood group genotyping. Vox Sang (2009) 1.42
Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time. Transfusion (2008) 1.41
The Bloodgen Project of the European Union, 2003-2009. Transfus Med Hemother (2009) 1.36
ABO glycosyltransferase genotyping by polymerase chain reaction using sequence-specific primers. Blood (1996) 1.33
Human neutrophil alloantigens. Vox Sang (2008) 1.24
Molecular testing for transfusion medicine. Curr Opin Hematol (2006) 1.22
International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report. Vox Sang (2011) 1.19
Blood group genotyping in Germany. Transfusion (2007) 1.15
Applications of DNA-based assays in blood group antigen and antibody identification. Transfusion (2003) 1.14
Rh phenotype prediction by DNA typing and its application to practice. Transfus Med (1998) 1.07
Future of molecular testing for red blood cell antigens. Clin Lab Med (2010) 1.07
Application of RHD and RHCE genotyping for correct blood group determination in chronically transfused patients. Transfusion (1999) 1.06
Report of the fourth International Workshop on molecular blood group genotyping. Vox Sang (2011) 1.02
DNA typing of recipient blood after massive transfusion. Transfusion (1998) 1.01
Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia. Transfusion (2011) 1.00
Report of the Second International Workshop on molecular blood group genotyping. Vox Sang (2007) 0.99
Molecular basis of NB1 (HNA-2a, CD177) deficiency. Blood (2002) 0.95
Report on the second international granulocyte serology workshop. Transfusion (1997) 0.94
Consortium for Blood Group Genes (CBGG): 2009 report. Immunohematology (2010) 0.91
Developments in the definition and clinical impact of human neutrophil antigens. Curr Opin Hematol (2011) 0.90
External quality assessment of tumour marker analysis: state of the art and consequences for estimating diagnostic sensitivity and specificity. Ger Med Sci (2005) 0.88
Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy. Transfusion (2012) 0.88
Workshop report on the genotyping of blood cell alloantigens. Transfus Med (2001) 0.87
Genotyping of human neutrophil antigen-5a (Ond). Transfus Med (2005) 0.86
Applying molecular immunohematology discoveries to daily transfusion practice. Rev Bras Hematol Hemoter (2012) 0.85
Neutrophil alloantigens. Transfus Med Rev (2002) 0.85
Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology. Transfusion (2009) 0.85
Molecular immunohaematology round table discussions at the AABB Annual Meeting, Boston 2012. Blood Transfus (2013) 0.84
Quality and the college of american pathologists. Arch Pathol Lab Med (2011) 0.83
B-lymphoblastoid cell lines as a source of reference DNA for human platelet and neutrophil antigen genotyping. Transfusion (2000) 0.80
Report of the First International Workshop on molecular blood group genotyping. Vox Sang (2005) 0.79
Consortium for Blood Group Genes (CBGG): 2008 report. Immunohematology (2009) 0.79
Report on the Sixth International Society of Blood Transfusion Platelet Serology Workshop. Transfusion (1996) 0.78
Rh DNA--coordinator's report. Transfus Clin Biol (1996) 0.77
Results of the DGTI workshop on the evaluation of the reactivity of monoclonal anti-D. Beitr Infusionsther (1992) 0.77
International reference reagents to standardise blood group genotyping: evaluation of candidate preparations in an international collaborative study. Vox Sang (2012) 0.77
Report on the 1997 International Society of Blood Transfusion Workshop for Genotyping of Platelet Alloantigens. Platelet and Granulocyte Workshop ISBT. Transfus Med (1998) 0.76
Consortium for Blood Group Genes (CBGG): Miami 2006 report. Immunohematology (2007) 0.76
Consortium for Blood Group Genes (CBGG): 2007 report. Immunohematology (2007) 0.76
Inaugural meeting of the consortium for blood group genes (CBGG): a summary report. Immunohematology (2005) 0.76
Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect Immun (2009) 3.31
Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum (2010) 2.05
The junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo. J Biol Chem (2004) 1.89
TLR7 ligands induce higher IFN-alpha production in females. J Immunol (2006) 1.88
Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies. Blood (2010) 1.62
Sepsis syndrome and death in trauma patients are associated with variation in the gene encoding tumor necrosis factor. Crit Care Med (2008) 1.53
A variable number of tandem repeats polymorphism influences the transcriptional activity of the neonatal Fc receptor alpha-chain promoter. Immunology (2006) 1.36
Anti-protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis. Blood (2013) 1.15
The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactions. J Biol Chem (2005) 1.07
Identification of novel transcriptional regulators involved in macrophage differentiation and activation in U937 cells. BMC Immunol (2009) 1.06
Natural and synthetic TLR7 ligands inhibit CpG-A- and CpG-C-oligodeoxynucleotide-induced IFN-alpha production. J Immunol (2007) 1.05
Polymorphisms in the human surfactant protein-D (SFTPD) gene: strong evidence that serum levels of surfactant protein-D (SP-D) are genetically influenced. Immunogenetics (2005) 1.01
Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia. Transfusion (2011) 1.00
Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections. Transfusion (2006) 0.96
Human monocytes represent a competitive source of interferon-alpha in peripheral blood. Clin Immunol (2008) 0.95
Heterogeneity of respiratory dendritic cell subsets and lymphocyte populations in inbred mouse strains. Respir Res (2012) 0.93
Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia. Transfusion (2008) 0.92
Transfusion-associated graft-versus-host disease. Transfus Med Rev (2009) 0.91
Does a negative direct antiglobulin test exclude warm autoimmune haemolytic anaemia? A prospective study of 504 cases. Br J Haematol (2006) 0.91
Anti-human neutrophil antigen-3a induced transfusion-related acute lung injury in mice by direct disturbance of lung endothelial cells. Arterioscler Thromb Vasc Biol (2013) 0.89
Heparin-coated colloidal mesoporous silica nanoparticles efficiently bind to antithrombin as an anticoagulant drug-delivery system. Chemistry (2011) 0.89
Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP). Eur J Haematol (2011) 0.89
Modulation of respiratory dendritic cells during Klebsiella pneumonia infection. Respir Res (2013) 0.88
Good manufacturing practice-compliant animal-free expansion of human bone marrow derived mesenchymal stroma cells in a closed hollow-fiber-based bioreactor. Biochem Biophys Res Commun (2012) 0.87
Host defence lectins in preterm neonates. Acta Paediatr (2005) 0.86
Human platelets target dendritic cell differentiation and production of proinflammatory cytokines. Transfusion (2006) 0.86
Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology. Transfusion (2009) 0.85
Successful use of miniphotopheresis for the treatment of graft-versus-host disease. Transfusion (2014) 0.85
Pathogenesis and mechanisms of antibody-mediated hemolysis. Transfusion (2015) 0.85
Prospective analysis of single nucleotide polymorphisms of the transforming growth factor beta-1 gene in Peyronie's disease. J Urol (2003) 0.84
Evaluation of a new nanoparticle-based lateral-flow immunoassay for the exclusion of heparin-induced thrombocytopenia (HIT). Thromb Haemost (2011) 0.84
Association of polymorphisms in the human surfactant protein-D (SFTPD) gene and postnatal pulmonary adaptation in the preterm infant. Acta Paediatr (2008) 0.83
The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation. Cell Immunol (2011) 0.83
Glycosylation of autoantibodies: insights into the mechanisms of immune thrombocytopenia. Thromb Haemost (2013) 0.83
Treatment of fetomaternal neonatal alloimmune thrombocytopenia with random platelets. Pediatr Blood Cancer (2008) 0.83
Effects of common atopy-associated amino acid substitutions in the IL-4 receptor alpha chain on IL-4 induced phenotypes. Immunogenetics (2005) 0.83
White blood cell-reactive antibodies are undetectable in solvent/detergent plasma. Transfusion (2005) 0.82
A new platelet alloantigen, Swi(a) , located on glycoprotein Ia identified in a family with fetal and neonatal alloimmune thrombocytopenia. Transfusion (2011) 0.80
Implication of transfected cell lines for the detection of alloantibodies against human neutrophil antigen-3. Transfusion (2011) 0.80
A point mutation in the EGF-4 domain of β(3) integrin is responsible for the formation of the Sec(a) platelet alloantigen and affects receptor function. Thromb Haemost (2011) 0.80
The implementation of surface plasmon resonance technique in monitoring pregnancies with expected fetal and neonatal alloimmune thrombocytopenia. Transfusion (2012) 0.80
Systemic hypersensitivity reaction mimicking anaphylaxis after first filgrastim administration in a healthy donor. Transfusion (2013) 0.80
A single center comparison between three different apheresis systems for autologous and allogeneic stem cell collections. Transfus Apher Sci (2013) 0.80
Skin TLR7 triggering promotes accumulation of respiratory dendritic cells and natural killer cells. PLoS One (2012) 0.79
Primary MHC-class II(+) cells are necessary to promote resting Vδ2 cell expansion in response to (E)-4-hydroxy-3-methyl-but-2-enyl-pyrophosphate and isopentenyl pyrophosphate. J Immunol (2012) 0.79
[Diagnosis and therapy of autoimmune thrombocytopenia. Recommendations of a joint Expert Group of DGHO, DGTI, DTH]. Onkologie (2010) 0.79
Rapid screening of granulocyte antibodies with a novel assay: flow cytometric granulocyte immunofluorescence test. Transfusion (2009) 0.79
HNA-1d: a new human neutrophil antigen located on Fcγ receptor IIIb associated with neonatal immune neutropenia. Transfusion (2013) 0.79
Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie's disease. J Urol (2003) 0.79
Performance characteristics of two commercially available IgG-specific immunoassays in the assessment of heparin-induced thrombocytopenia (HIT). Thromb Res (2011) 0.79
Diclofenac-induced antibodies against red blood cells are heterogeneous and recognize different epitopes. Transfusion (2004) 0.78
NOS inhibition synchronizes calcium oscillations in human adipose tissue-derived mesenchymal stem cells by increasing gap-junctional coupling. J Cell Physiol (2011) 0.78
Transfusion-related acute lung injury: an overview. Curr Pharm Des (2012) 0.78
Rapid detection of HPA-1 alloantibodies by platelet antigens immobilized onto microbeads. Transfusion (2007) 0.78
Cutting edge: sanglifehrin A, a novel cyclophilin-binding immunosuppressant blocks bioactive IL-12 production by human dendritic cells. J Immunol (2003) 0.77
Immunisation against αIIbβ3 and αvβ3 in a type 1 variant of Glanzmann's thrombasthenia caused by a missense mutation Gly540Asp on β3. Thromb Haemost (2016) 0.77
Prevalence of hereditary antithrombin mutations is higher than estimated in patients with thrombotic events. Blood Coagul Fibrinolysis (2013) 0.77
Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications. Transfusion (2009) 0.77
Normal donor bone marrow is superior to Flt3 ligand-mobilized bone marrow in prolonging heart allograft survival when combined with anti-CD40L (CD154). Am J Transplant (2002) 0.76
Platelet destruction in immune thrombocytopenia. Understanding the mechanisms. Hamostaseologie (2015) 0.76
Rapid enzyme-linked immunosorbent assay for the detection of antibodies against human neutrophil antigens -1a, -1b, and -1c. Transfusion (2012) 0.76
Marked hyperbilirubinemia associated with the heme oxygenase-1 gene promoter microsatellite polymorphism in a boy with autoimmune hemolytic anemia. Pediatrics (2007) 0.76
Prediction of fetal status in fetal/neonatal alloimmune thrombocytopenia (FNAIT)? Blood (2011) 0.75
The cyclophilin-binding agent Sanglifehrin A is a dendritic cell chemokine and migration inhibitor. PLoS One (2011) 0.75
Flashback 1997: collection of hematopoietic progenitor cells by peripheral blood apheresis after stimulation with granulocyte-colony-stimulating factor. Transfusion (2017) 0.75
Multicentric validation of a rapid assay for heparin-induced thrombocytopenia with different specimen types. Blood Coagul Fibrinolysis (2014) 0.75
Transfused neutrophils home to a joint with fungal infection. Transfusion (2016) 0.75
Acanthocytes in the McLeod phenotype of X-linked chronic granulomatous disease. Transfusion (2017) 0.75
[Transfusion-related acute lung injury (TRALI)]. Anasthesiol Intensivmed Notfallmed Schmerzther (2007) 0.75
Partially desulfated heparin modulates the interaction between anti-protamine/heparin antibodies and platelets. Thromb Haemost (2015) 0.75
Alpha-1-antitrypsin levels and genetic variation of the alpha-1-antitrypsin gene in Peyronie's disease. Eur Urol (2004) 0.75
Thrombotic thrombocytopenic purpura with unusual 33 recurrences: a case report. Ann Clin Lab Sci (2013) 0.75
Hemolytic transfusion reaction mimicked by occult retroperitoneal bleeding. Transfusion (2013) 0.75
Tumor necrosis factor alpha gene variants do not display allelic imbalance in circulating myeloid cells. Cell Immunol (2010) 0.75
Non-transient "self-sustaining" heparin-induced thrombocytopenia: 4-year persistence of a platelet-activating PF4/heparin-antibody status without heparin exposure. Platelets (2013) 0.75